// App-Quantinova.ai

P4-01-02 : Prospective characterization of HER2-positive circulating tumor cells in patients with HER2-negative metastatic breast cancer

Researchers

Presenter

  • Krop IE

Principal Investigators

  • Macrae E

  • Galler SR

  • Sales E

  • Huynh L

  • Mitchell C

  • Clarin-Tamayo T

  • Anderson M

  • Abad L

  • Winer E

  • Bischoff F

  • Fauni R

Medical Centers

  • The Ohio State Univerisity, Columbus, OH

  • Biocept, Inc, San Diego, CADana-Farber Cancer Institute, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved